An Overview of Sustiva (Efavirenz, Stocrin)
August 23, 2013
Brand Name: Sustiva
Efavirenz can cause serious, life-threatening side effects. These include serious psychiatric problems and liver problems.
Contact your health care provider right away if you have any of the following symptoms that may signal psychiatric problems:
Some people taking efavirenz have experienced serious liver problems. This usually occurred in people with a chronic liver disease (such as hepatitis infection), but there have also been a few reports in people without any existing liver disease. Tell your health care provider if you notice any side effects while taking efavirenz.
Women should not become pregnant while taking efavirenz and for 12 weeks after stopping the drug. Serious birth defects have been seen in the babies of animals and women treated with efavirenz during pregnancy. Whether efavirenz caused the birth defects is unknown.
While taking efavirenz, it is important to keep all of your appointments with your health care provider.
What is efavirenz?
Efavirenz is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and in children 3 months of age and older who weigh at least 3.5 kilograms (7 pounds 12 ounces). Efavirenz is always used in combination with other anti-HIV medicines.
Efavirenz is a type of anti-HIV medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI). NNRTIs work by binding to and blocking HIV reverse transcriptase, an HIV enzyme. This prevents HIV from replicating and lowers the amount of HIV in the blood.
Efavirenz does not cure HIV/AIDS. It is not known if efavirenz reduces the risk of passing HIV to other people.
What should I tell my health care provider before taking efavirenz?
Before taking efavirenz, tell your health care provider:
This article was provided by AIDSinfo. Visit the AIDSinfo website to find out more about their activities and publications.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)